home / stock / bpts / bpts news

BPTS News and Press, Biophytis SA From 08/13/21

Stock Information
Company Name: Biophytis SA
Stock Symbol: BPTS
Market: NASDAQ
Menu
BPTS BPTS Quote BPTS Short BPTS News BPTS Articles BPTS Message Board
Get BPTS Alerts

News, Short Squeeze, Breakout and More Instantly...
BPTS - Biophytis Announces the Issue of 4,950,000 New Shares in a Capital Increase Reserved for NEGMA and the Performance of the Judgments of March 16, 2021 and July 16, 2021

PARIS and CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative...
BPTS - Biophytis Announces Top Line Results of SARA-INT Phase 2 Study With Sarconeos (BIO101) in Sarcopenia

Sarconeos (BIO101) at the highest dose (350 mg bid) showed a clinically meaningful improvement in the 400-meter walk test (400MWT), the primary endpoint of the study Sarconeos (BIO101) showed a very good safety profile at the doses of 175 mg bid and of 350 mg bid with no Serious Adver...

BPTS - Judgment Rendered on July 16, 2021 in the Proceedings Between Biophytis and Negma Group Ltd by the Execution Judge From the Paris Court of Justice

PARIS and CAMBRIDGE, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative...

BPTS - Biophytis presents positive preclinical data on Sarconeos in COVID-19 at ECCMID 2021

Biophytis (BPTS) announces new positive preclinical data on Sarconeos (BIO101) in hamsters infected with SARS-CoV-2. In the study, hamsters were inoculated intranasally with 106 TCID50/mL. Sarconeos (BIO101) was administered daily at 10 mg/kg*day. In animals treated with Sarconeos (BIO101), t...
BPTS - Biophytis Presents Positive Preclinical Data on Sarconeos (BIO101) in COVID-19 at ECCMID 2021

PARIS and CAMBRIDGE, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing...

BPTS - Biophytis appoints Benoit Canolle as CBO, Jean Mariani as interim CMO

Biophytis (BPTS) announces two new appointments of healthcare executives. Benoit Canolle has been named chief business officer, or CBO, and will be member of the executive committee. Jean Mariani, chairman of the Biophytis scientific committee will replace Sam Agus as chief medical offic...

BPTS - Biophytis Reinforces Leadership Teams with Three Senior Appointments

Claude Allary to be member of Board of Directors Benoit Canolle is appointed Chief Business Officer Jean Mariani, Chairman of Biophytis Scientific Committee to take over the Chief Medical Officer role PARIS and CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) -...
BPTS - Biophytis Secures the Manufacturing of Sarconeos (BIO101) for COVID-19 with a Global CDMO & Announces the Next Milestones for the COVA Phase 2-3 Study

The Company signed contracts for the manufacturing of registration batches in view of the potential application for Emergency Use Authorization to FDA and/or Conditional Marketing Authorization to EMA The 155 th patient has completed treatment in Part 2 of the COVA P...

BPTS - Results of Biophytis SARA-INT Phase 2 Trial with Sarconeos (BIO101) in Sarcopenia will be Released by August 2021

PARIS and CAMBRIDGE, Mass., June 30, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “company”),a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing ...

BPTS - Biophytis announces new convertible bond financing for up to Euro32 million with Atlas and drawing of 2 tranches under the 2020 Atlas Contract for Euro6 million

PARIS and Cambridge, Mass., June 19, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Nasdaq CM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics aimed at slowing the dege...
Previous 10 Next 10